Making the case for the case report - informing physicians of intracranial hypertension as an adverse event in tyrosine kinase inhibitor treated chronic myeloid leukemia patients

MeSH terms

• Humans
• Intracranial Hypertension* / chemically induced
• Intracranial Hypertension* / diagnosis
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / diagnosis
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
• Physicians*
• Protein Kinase Inhibitors / adverse effects